{"id":25633,"date":"2024-05-15T12:11:05","date_gmt":"2024-05-15T10:11:05","guid":{"rendered":"https:\/\/idibell.cat\/?p=25633"},"modified":"2024-05-15T12:11:05","modified_gmt":"2024-05-15T10:11:05","slug":"la-fundacio-privada-daniel-bravo-andreu-beca-a-alexandra-pons-del-grup-de-recerca-bio-heart","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2024\/05\/la-fundacio-privada-daniel-bravo-andreu-beca-a-alexandra-pons-del-grup-de-recerca-bio-heart\/","title":{"rendered":"La Fundaci\u00f3 Privada Daniel Bravo Andreu beca a Alexandra Pons, del grup de recerca BIO-HEART"},"content":{"rendered":"<p>La <a href=\"http:\/\/www.fundaciodanielbravo.org\/\">Fundaci\u00f3 Privada Daniel Bravo Andreu<\/a> ha atorgat tres beques per a estades curtes d&#8217;investigaci\u00f3 biom\u00e8dica en centres de prestigi a l&#8217;estranger, entre les quals destaca l\u2019ajuda a <strong>Alexandra Pons<\/strong> de l&#8217;<a href=\"https:\/\/bellvitgehospital.cat\/ca\">Hospital Universitari de Bellvitge<\/a> (HUB) &#8211; <a href=\"https:\/\/idibell.cat\/\">Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge<\/a> (IDIBELL) per anar a l&#8217;Hospital Royal Brompton de Londres. Els altres dos premiats han sigut el <strong>Jean-Baptiste Guichard<\/strong> de l&#8217;<a href=\"https:\/\/www.clinicbarcelona.org\/ca\">Hospital Cl\u00ednic Barcelona<\/a> i <strong>Maria Inmaculada Villanueva<\/strong> de la <a href=\"https:\/\/www.upf.edu\/\">Universitat Pompeu Fabra<\/a> (UPF).<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Diagn\u00f2stic preco\u00e7 de cardiotoxicitat en pacients oncol\u00f2gics<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Alexandra Pons \u00e9s metgessa especialista en insufici\u00e8ncia card\u00edaca i oncocardiologia al Servei de Cardiologia del HUB i la Unitat de Cardiooncologia de l&#8217;Institut Catal\u00e0 d&#8217;Oncologia (ICO) i investigadora al Grup de Recerca en Malalties Cardiovasculars (BIO-HEART) de l&#8217;IDIBELL. Actualment, est\u00e0 duent a terme el doctorat a la Universitat de Barcelona (UB).<\/p>\n<p>&nbsp;<\/p>\n<p>Pons ha escollit fer una estada de nou mesos a l&#8217;<a href=\"https:\/\/www.rbht.nhs.uk\/\">Hospital Royal Brompton<\/a> a Londres, del Servei Nacional de Salut brit\u00e0nic (NHS), per dur a terme el projecte <em>Clinical impact of early detection of cardiotoxicity using Fast Strain-Encoded Cardiac Magnetic Resonance in cancer patients undergoing chemotherapy<\/em>.<\/p>\n<p>&nbsp;<\/p>\n<p>Hi ha diversos tractaments oncol\u00f2gics que poden ser t\u00f2xics per al miocardi i provocar disfunci\u00f3 ventricular i insufici\u00e8ncia card\u00edaca als pacients. L&#8217;objectiu del projecte becat per la Fundaci\u00f3 Privada Daniel Bravo Andreu \u00e9s saber si l&#8217;<em>strain<\/em> mioc\u00e0rdic (<strong>MyoStrain<\/strong>) en la resson\u00e0ncia magn\u00e8tica card\u00edaca (RMc) \u00e9s un bon m\u00e8tode per diagnosticar en etapes inicials i monitoritzar la cardiotoxicitat dels pacients amb c\u00e0ncer.<\/p>\n<p>&nbsp;<\/p>\n<p>\u201cSabem que la RMc \u00e9s una bona eina per al diagn\u00f2stic i la monitoritzaci\u00f3 de la cardiotoxicitat, amb un augment de sensibilitat respecte l&#8217;ecocardiografia. Si podem demostrar que l&#8217;\u00fas de MyoStrain en la RMc \u00e9s capa\u00e7 de diagnosticar la cardiotoxicitat en fases subcl\u00edniques, ser\u00e0 un gran aven\u00e7 ja que permetr\u00e0 iniciar un tractament cardioprotector de forma preco\u00e7 amb un probable impacte positiu en el pron\u00f2stic dels pacients\u201d, explica el <strong>Dr. Josep Com\u00edn<\/strong>, cap del grup BIO-HEART i mentor d&#8217;Alexandra Pons.<\/p>\n<p>&nbsp;<\/p>\n<p>\u201cAl finalitzar la resid\u00e8ncia en cardiologia m&#8217;he centrat en el camp de la cardiooncologia amb el desig de millorar el pron\u00f2stic dels pacients amb c\u00e0ncer i participar en el desenvolupament cient\u00edfic present i futur d&#8217;aquest camp en expansi\u00f3. La <strong>Beca Daniel Bravo \u00e9s una oportunitat \u00fanica de col\u00b7laborar amb un centre pioner<\/strong>\u201d remarca Alexandra Pons.<\/p>\n<p>&nbsp;<\/p>\n<p>El mentor de la investigadora catalana a l&#8217;Hospital Royal Brompton ser\u00e0 el <strong>Dr. Alexander Lyon<\/strong>, cardi\u00f2leg consultor honorari i director de la Unitat d&#8217;Investigaci\u00f3 Biom\u00e8dica Cardiovascular de l&#8217;Hospital Royal Brompton.<\/p>\n<p>&nbsp;<\/p>\n<p>Les altres dues beques s&#8217;han atorgat al Dr. Jean-Baptiste Guichard, electrofisi\u00f2leg card\u00edac i investigador postdoctoral a la Unitat d&#8217;Arr\u00edtmies de l&#8217;Hospital Cl\u00ednic, que realitzar\u00e0 la seva estada a l&#8217;<a href=\"https:\/\/www.imperial.ac.uk\/\">Imperial College London<\/a>; i a l&#8217;enginyera en f\u00edsica i computaci\u00f3 biom\u00e8dica Maria Inmaculada Villanueva, del Departament de Tecnologies de la Informaci\u00f3 i les Comunicacions de la UPF, que far\u00e0 una estada de quatre mesos al Departament de Qu\u00edmica, Materials i Enginyeria Qu\u00edmica de la <a href=\"https:\/\/www.polimi.it\/en\">Universitat Politecnico di Milano<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gr\u00e0cies a l\u2019ajuda, la investigadora de l\u2019IDIBELL i l\u2019Hospital Universitari de Bellvitge podr\u00e0 fer una estada de recerca a l&#8217;Hospital Royal Brompton de Londres.<\/p>\n","protected":false},"author":8,"featured_media":25634,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[359,334,466],"tags":[],"class_list":["post-25633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-malalties-cardiovasculars","category-medicina-translacional","category-p-de-malalties-cardiovasculars-respiratories-sistemiques-i-denvelliment-cellular"],"publishpress_future_action":{"enabled":false,"date":"2025-01-02 20:26:11","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=25633"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25633\/revisions"}],"predecessor-version":[{"id":25635,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25633\/revisions\/25635"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/25634"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=25633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=25633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=25633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}